Literature DB >> 22279110

Effect of cardiac resynchronization therapy in patients without left intraventricular dyssynchrony.

Dominique Auger1, Gabe B Bleeker, Matteo Bertini, See H Ewe, Rutger J van Bommel, Tomasz G Witkowski, Arnold C T Ng, Lieselot van Erven, Martin J Schalij, Jeroen J Bax, Victoria Delgado.   

Abstract

AIMS: To evaluate the effects of cardiac resynchronization therapy (CRT) on long-term survival of patients without baseline left ventricular (LV) mechanical dyssynchrony. METHODS AND
RESULTS: A total of 290 heart failure patients (age 67 ± 10 years, 77% males) without significant baseline LV dyssynchrony (<60 ms as assessed with tissue Doppler imaging) were treated with CRT. Patients were divided according to the median LV dyssynchrony measured after 48 h of CRT into two groups. All-cause mortality was compared between the subgroups. In addition, the all-cause mortality rates of these subgroups were compared with the all-cause mortality of 290 heart failure patients treated with CRT who showed significant LV dyssynchrony (≥60 ms) at baseline. In the group of patients without significant LV dyssynchrony, median LV dyssynchrony increased from 22 ms (inter-quartile range 16-34 ms) at baseline to 40 ms (24-56 ms) 48 h after CRT. The cumulative mortality rates at 1-, 2-, and 3-year follow-up of patients with LV dyssynchrony ≥40 ms 48 h after CRT implantation were significantly higher when compared with patients with LV dyssynchrony <40 ms (10, 17, and 23 vs. 3, 8, and 10%, respectively; log-rank P< 0.001). Finally, the cumulative mortality rates at 1-, 2-, and 3-year follow-up of patients with baseline LV dyssynchrony were 3, 8, and 11%, respectively (log-rank P= 0.375 vs. patients with LV dyssynchrony <40 ms). Induction of LV dyssynchrony after CRT was an independent predictor of mortality (hazard ratio: 1.247; P= 0.009).
CONCLUSION: In patients without significant LV dyssynchrony, the induction of LV dyssynchrony after CRT may be related to a less favourable long-term outcome.

Entities:  

Mesh:

Year:  2012        PMID: 22279110      PMCID: PMC3345550          DOI: 10.1093/eurheartj/ehr468

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  32 in total

1.  2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association.

Authors:  Kenneth Dickstein; Panos E Vardas; Angelo Auricchio; Jean-Claude Daubert; Cecilia Linde; John McMurray; Piotr Ponikowski; Silvia Giuliana Priori; Richard Sutton; Dirk J van Veldhuisen
Journal:  Eur Heart J       Date:  2010-08-27       Impact factor: 29.983

2.  When right may not be right: right bundle-branch block and response to cardiac resynchronization therapy.

Authors:  Karoly Kaszala; Kenneth A Ellenbogen
Journal:  Circulation       Date:  2010-11-01       Impact factor: 29.690

3.  Relationship of echocardiographic dyssynchrony to long-term survival after cardiac resynchronization therapy.

Authors:  John Gorcsan; Olusegun Oyenuga; Phillip J Habib; Hidekazu Tanaka; Evan C Adelstein; Hideyuki Hara; Dennis M McNamara; Samir Saba
Journal:  Circulation       Date:  2010-10-25       Impact factor: 29.690

4.  Effects of cardiac resynchronization therapy on left ventricular twist.

Authors:  Matteo Bertini; Nina Ajmone Marsan; Victoria Delgado; Rutger J van Bommel; Gaetano Nucifora; C Jan Willem Borleffs; Giuseppe Boriani; Mauro Biffi; Eduard R Holman; Ernst E van der Wall; Martin J Schalij; Jeroen J Bax
Journal:  J Am Coll Cardiol       Date:  2009-09-29       Impact factor: 24.094

5.  Value of tissue Doppler echocardiography in predicting response to cardiac resynchronization therapy in patients with heart failure.

Authors:  Rutger J Van Bommel; Claudia Ypenburg; C Jan Willem Borleffs; Victoria Delgado; Nina Ajmone Marsan; Matteo Bertini; Eduard R Holman; Martin J Schalij; Jeroen J Bax
Journal:  Am J Cardiol       Date:  2010-02-20       Impact factor: 2.778

6.  Morbidity and mortality in heart failure patients treated with cardiac resynchronization therapy: influence of pre-implantation characteristics on long-term outcome.

Authors:  Rutger J van Bommel; Carel Jan Willem Borleffs; Claudia Ypenburg; Nina Ajmone Marsan; Victoria Delgado; Matteo Bertini; Ernst E van der Wall; Martin J Schalij; Jeroen J Bax
Journal:  Eur Heart J       Date:  2010-08-07       Impact factor: 29.983

7.  Characteristics of heart failure patients associated with good and poor response to cardiac resynchronization therapy: a PROSPECT (Predictors of Response to CRT) sub-analysis.

Authors:  Rutger J van Bommel; Jeroen J Bax; William T Abraham; Eugene S Chung; Luis A Pires; Luigi Tavazzi; Peter J Zimetbaum; Bart Gerritse; Nina Kristiansen; Stefano Ghio
Journal:  Eur Heart J       Date:  2009-08-30       Impact factor: 29.983

8.  Biventricular pacing worsened dyssynchrony in heart failure patient with right-bundle branch block.

Authors:  Masaki Tanabe; Kaoru Dohi; Katsuya Onishi; Tomoyuki Nakata; Yuichi Sato; Hiroshi Nakajima; Takeshi Takamura; Masatoshi Miyahara; Mashio Nakamura; Kan Takeda; Masaaki Ito
Journal:  Int J Cardiol       Date:  2008-08-15       Impact factor: 4.164

9.  Analysis of ventricular activation using surface electrocardiography to predict left ventricular reverse volumetric remodeling during cardiac resynchronization therapy.

Authors:  Michael O Sweeney; Rutger J van Bommel; Martin J Schalij; C Jan Willem Borleffs; Anne S Hellkamp; Jeroen J Bax
Journal:  Circulation       Date:  2010-01-25       Impact factor: 29.690

10.  Association of intraventricular mechanical dyssynchrony with response to cardiac resynchronization therapy in heart failure patients with a narrow QRS complex.

Authors:  Rutger J van Bommel; Hidekazu Tanaka; Victoria Delgado; Matteo Bertini; Carel Jan Willem Borleffs; Nina Ajmone Marsan; Johannes Holzmeister; Frank Ruschitzka; Martin J Schalij; Jeroen J Bax; John Gorcsan
Journal:  Eur Heart J       Date:  2010-09-23       Impact factor: 29.983

View more
  8 in total

1.  Can cardiac resynchronization therapy cause harm?

Authors:  John E Sanderson; Cheuk-Man Yu
Journal:  Eur Heart J       Date:  2012-01-31       Impact factor: 29.983

Review 2.  Nuclear Image-Guided Approaches for Cardiac Resynchronization Therapy (CRT).

Authors:  Weihua Zhou; Ernest V Garcia
Journal:  Curr Cardiol Rep       Date:  2016-01       Impact factor: 2.931

3.  Biventricular pacing in heart failure: right is not wrong!

Authors:  Prem Soman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-06       Impact factor: 9.236

Review 4.  Cellular and Molecular Aspects of Dyssynchrony and Resynchronization.

Authors:  Jonathan A Kirk; David A Kass
Journal:  Card Electrophysiol Clin       Date:  2015-12

Review 5.  Electromechanical dyssynchrony and resynchronization of the failing heart.

Authors:  Jonathan A Kirk; David A Kass
Journal:  Circ Res       Date:  2013-08-30       Impact factor: 17.367

6.  Electrophysiologic mechanism of deteriorating cardiac function in a patient with inappropriate CRT indication and frequent ventricular ectopy.

Authors:  Junjie Zhang; Daniel H Cooper; Yoram Rudy
Journal:  Pacing Clin Electrophysiol       Date:  2013-06-10       Impact factor: 1.976

7.  Prediction of response to cardiac resynchronization therapy using left ventricular pacing lead position and cardiovascular magnetic resonance derived wall motion patterns: a prospective cohort study.

Authors:  Gregory R Hartlage; Jonathan D Suever; Stephanie Clement-Guinaudeau; Patrick T Strickland; Nima Ghasemzadeh; R Patrick Magrath; Ankit Parikh; Stamatios Lerakis; Michael H Hoskins; Angel R Leon; Michael S Lloyd; John N Oshinski
Journal:  J Cardiovasc Magn Reson       Date:  2015-07-14       Impact factor: 5.364

8.  Multimodality imaging: Bird's eye view from The European Society of Cardiology Congress 2015 London, August 29-September 2, 2015.

Authors:  Jeroen J Bax; Victoria Delgado; Stephan Achenbach; Udo Sechtem; Juhani Knuuti
Journal:  J Nucl Cardiol       Date:  2015-12       Impact factor: 5.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.